Biomagnetics Diagnostics Corp. (Pink Sheets:BMGP), a developer of revolutionary diagnostic systems and technology for malaria, HIV/AIDS, hepatitis, tuberculosis and detection, announced today the implementation of a program to accelerate the availability of the world’s first Integrated Optical BioSensor (IOBS) platform. The Company is currently reviewing research and manufacturing partnerships to develop simple to replicate bench top versions of the IOBS platform on which single pathogen or multiple pathogen testing assay cartridges can be developed…

See the rest here: 
Biomagnetics To Accelerate Availability Of The World’s First Integrated Optical Biosensor For Malaria, Cholera, TB And HIV/AIDS Diagnosis

You may also like:

• GI Dynamics’ EndoBarrier™ Gastrointestinal Liner To Be Highlighted At Upcoming Cleveland Clinic Conference
• Transforming Community Services - SHAs To Play A Crucial Role In Supporting PCTs
• Biomagnetics To Hold Investor Conference Call To Introduce World Class Biosensor Technology For Malaria, HIV And Tuberculosis Diagnosis
• Drug Companies Called On To Pool HIV Patents
• Transposagen Creates A Rat Model Of The Human Immune System
• South African AIDS Advocate Who Created Radio Diaries Dies Of Drug-Resistant TB
• Lineagen, Inc. Selected To Present At The 2010 Genetic Risk Factors For Autism: Translating Discoveries Into Diagnostics Symposium In Toronto
• Commitments To Global HIV/AIDS Programs Falter For ‘First Time In 15 Years,’ UNAIDS Chief Says
• Merck Provides New Funding To Fight HIV/AIDS In Botswana
• Cancer Is The World’s Top ‘Economic Killer,’ Report Finds